Quantcast
Last updated on April 21, 2014 at 9:29 EDT

Latest Intravenous fluids Stories

2010-09-27 07:00:00

SAN DIEGO, Sept. 27 /PRNewswire/ -- Clinicians from three U.S. hospitals today reported significant progress in the fight against deadly IV catheter-related bloodstream infections (CRBSI). Data analyzed and presented by clinicians from St. Joseph's Mercy Hospital in Hot Springs, Ark.; Bethesda North Hospital in Cincinnati; and the VA Medical Center in Seattle showed that the hospitals virtually eliminated such infections, which annually kill some 62,500 hospital patients nationwide....

2010-04-05 07:00:00

SAN DIEGO, April 5 /PRNewswire-FirstCall/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical device company, today announced an agreement to acquire Medegen, a leading innovator in clinically differentiated needleless access valves and administration sets that deliver intravenous (IV) medication to patients, for $225 million in cash. "Medegen is an ideal strategic fit with CareFusion due to the complementary nature of our infusion product lines, R&D investments, and our focus...

2010-01-22 13:49:28

Pediatric hospitals can significantly decrease the number of bloodstream infections from central venous catheters by following some low-tech rules: Insert the catheter correctly and, above all, keep everything squeaky clean after that. Yearlong research led by Marlene Miller, M.D. Ms.C., of the Johns Hopkins Children's Center with colleagues from other hospitals saw a 43 percent drop in the rate of bloodstream infections from catheters in 29 pediatric intensive care units (PICUs) that focused...

2009-11-30 08:00:00

BOZEN, Italy, November 30 /PRNewswire/ -- Health Robotics today announced its plans to unveil TPNstation's development plans and product specifications for a new and revolutionary concept: "Totally Automated Parenteral Nutrition", a new key component of its i.v. Room of the Future vision to be showcased at Las Vegas' ASHP (Booth # 114). "I look forward to see the reaction from our customers to the TPNstation's blueprints and to find out if TPNstation appears to meet their prior...

2009-11-18 11:48:00

NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Intravenous Equipment - A World Market Intelligence Report http://www.reportlinker.com/p0164326/Intravenous-Equipment---A-World-Market-Intelligence-Report.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Intravenous equipment enables the delivery of medications directly into the patient's circulatory system. Safety issues involving...

2009-06-29 08:00:00

BOZEN , Italy, June 29 /PRNewswire/ -- Health-Robotics today announced that it has signed an exclusive 5-year strategic partnership with Grifols S.A., the leading Pharmacy Automation provider in Spain, Portugal, and South America. Grifols desires to safely, accurately, and cost-effectively automate the preparation of non-hazardous IV Admixtures with Health Robotics' i.v.STATION Robot. As part of this strategic partnership, Grifols will take delivery of 120 i.v.STATION Robots between now...

2009-02-12 09:52:00

PHILADELPHIA, Feb. 12 /PRNewswire-USNewswire/ -- When treating children for acute osteomyelitis--a bacterial bone infection--an early changeover from intravenous (IV) antibiotic delivery to oral antibiotics is just as effective as continuing the IV therapy, according to pediatric researchers. In addition, the oral drugs are more convenient for children and families, and avoid a major drawback of IV use: increased risk of complications from using central catheters, such as infections or...

2008-11-13 06:00:36

Ekr Therapeutics, a specialty pharmaceutical company, has received the FDA approval for double concentration Cardene IV premixed injection. These patented 200ml ready-to-use (RTU) intravenous bags contain 40mg of the calcium channel blocker nicardipine hydrochloride (0.2mg/ml) in either dextrose or sodium chloride. Previously, the company received the FDA approval for standard, or single (1X), concentration Cardene IV RTU bags. The 1X preparations consist of 200ml premixed bags...

2008-09-02 15:00:30

B. Braun Medical Inc. today announced it had received 510(k) clearance from the FDA for the industry's first silver-impregnated antibacterial Luer Access Device (LAD) designed to reduce potential catheter-related bloodstream infections. B. Braun's ULTRASITE(R) Ag Luer Access Device uses a controlled release silver ion technology that effectively achieves 4-log (99.99%) reductions in bacteria Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter aerogenes and 3-log (99.9%)...

2008-08-05 09:01:32

EKR Therapeutics has received approval from the FDA for Cardene I.V. premixed injection, a patented, ready-to-use, single use intravenous bag for the administration of this calcium channel blocker. The Cardene I.V. 200ml ready-to-use (RTU) bags contain 20mg of the anti-hypertensive agent nicardipine hydrochloride (0.1mg/ml) in either dextrose or sodium chloride. EKR further noted that it will start taking orders immediately for the new RTU bags of Cardene. The RTU formulations are...


Latest Intravenous fluids Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

More Articles (1 articles) »